IRIS
MELAIU, OMBRETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.676
AS - Asia 1.525
EU - Europa 1.227
SA - Sud America 256
Continente sconosciuto - Info sul continente non disponibili 241
AF - Africa 28
OC - Oceania 2
Totale 5.955
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.609
SG - Singapore 645
IT - Italia 541
CN - Cina 227
BR - Brasile 219
HK - Hong Kong 204
RU - Federazione Russa 186
VN - Vietnam 142
IE - Irlanda 119
BD - Bangladesh 97
JP - Giappone 76
DE - Germania 75
FI - Finlandia 74
NL - Olanda 66
GB - Regno Unito 50
CA - Canada 37
IN - India 32
FR - Francia 29
ID - Indonesia 20
AT - Austria 16
ES - Italia 16
MX - Messico 15
SE - Svezia 15
AR - Argentina 13
IQ - Iraq 11
TR - Turchia 11
EC - Ecuador 10
PL - Polonia 10
ZA - Sudafrica 8
MA - Marocco 7
MY - Malesia 7
TH - Thailandia 7
KR - Corea 6
PH - Filippine 6
UA - Ucraina 5
UZ - Uzbekistan 5
AL - Albania 4
CL - Cile 4
CO - Colombia 4
CZ - Repubblica Ceca 4
HN - Honduras 4
PK - Pakistan 4
DZ - Algeria 3
JO - Giordania 3
KE - Kenya 3
NP - Nepal 3
PY - Paraguay 3
SA - Arabia Saudita 3
AU - Australia 2
BB - Barbados 2
EG - Egitto 2
GI - Gibilterra 2
GT - Guatemala 2
IR - Iran 2
JM - Giamaica 2
KW - Kuwait 2
LT - Lituania 2
LV - Lettonia 2
PT - Portogallo 2
RS - Serbia 2
SI - Slovenia 2
TN - Tunisia 2
TW - Taiwan 2
VE - Venezuela 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
BZ - Belize 1
CH - Svizzera 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LY - Libia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
Totale 5.716
Salva come PNG Salva come JPEG
Città #
Singapore 381
San Jose 306
Hong Kong 202
Rome 182
Chandler 146
Ashburn 136
Dublin 119
New York 105
Council Bluffs 100
Beijing 85
Los Angeles 83
Tokyo 71
Santa Clara 61
The Dalles 59
Wilmington 57
Atlanta 48
Waller 47
Buffalo 46
Chicago 43
Helsinki 40
Ho Chi Minh City 37
Milan 37
Hanoi 36
Hickman 36
Fairfield 34
Savannah 34
Stone Mountain 34
Burbank 32
São Paulo 31
Lappeenranta 28
Moscow 28
Ann Arbor 26
Houston 24
Morton Grove 24
Dallas 20
Salt Lake City 19
Colorado Springs 18
Frankfurt am Main 18
London 18
Brooklyn 17
Munich 17
Indianapolis 16
Medford 16
Minneapolis 16
Benton Harbor 13
Baton Rouge 12
Forney 12
Jakarta 12
Johnson City 12
Lauterbourg 12
Seattle 12
Browns Mills 11
Genoa 11
Montreal 11
Da Nang 10
Elk Grove Village 10
Nuremberg 10
Tampa 10
Vienna 10
Woodbridge 10
Würzburg 10
Amsterdam 9
Orem 9
Phoenix 9
Redondo Beach 9
Toronto 9
Cambridge 8
Lawrence 8
Miami 8
Naples 8
San Diego 8
Bangkok 7
Boardman 7
Chennai 7
Lancaster 7
McDonough 7
Mülheim 7
Belo Horizonte 6
Boston 6
Des Moines 6
Engelhard 6
Haiphong 6
Manchester 6
Monte Vista 6
North Bergen 6
Seoul 6
Turin 6
Warsaw 6
Bologna 5
Charlotte 5
Columbus 5
Denver 5
Guangzhou 5
Hounslow 5
Las Vegas 5
Newark 5
Palermo 5
Philadelphia 5
Quito 5
Rio de Janeiro 5
Totale 3.374
Salva come PNG Salva come JPEG
Nome #
Identification of overexpressed genes in malignant pleural mesothelioma 468
ERAP1 promotes Hedgehog-dependent tumorigenesis by controlling USP47-mediated degradation of beta TrCP 182
DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy 174
Nutlin-3a Enhances Natural Killer Cell-Mediated Killing of Neuroblastoma by Restoring p53-Dependent Expression of Ligands for NKG2D and DNAM-1 Receptors 174
The Combination of Bioavailable Concentrations of Curcumin and Resveratrol Shapes Immune Responses While Retaining the Ability to Reduce Cancer Cell Survival 153
Autophagy inhibition enhances T and NK immunogenicity in neuroblastoma 145
ERAP1 controls the interaction of the inhibitory receptor KIR3DL1 with HLA-B51:01 by affecting natural killer cell function 143
Quantification of the immune content in neuroblastoma: Deep learning and topological data analysis in digital pathology 140
Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma 137
Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma 117
PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma 115
Biomarkers Identification in the Microenvironment of Oral Squamous Cell Carcinoma: A Systematic Review of Proteomic Studies 107
Polymorphisms within the RET proto-oncogene and risk of sporadic medullary thyroid carcinoma 103
DNA Damage Response Gene Signature as Potential Treatment Markers for Oral Squamous Cell Carcinoma 102
News on immune checkpoint inhibitors as immunotherapy strategies in adult and pediatric solid tumors 99
The Combination of Immune Checkpoint Blockade with Tumor Vessel Normalization as a Promising Therapeutic Strategy for Breast Cancer: An Overview of Preclinical and Clinical Studies 95
Identification of a Genetic Variation in ERAP1 Aminopeptidase that Prevents Human Cytomegalovirus miR-UL112-5p-Mediated Immunoevasion 94
The genetic susceptibility in the development of malignant pleural mesothelioma 93
Immunogenic cell death inducers in cancer immunotherapy to turn cold tumors into hot tumors 88
Neoadjuvant Treatment as a Risk Factor for Variation of Upper Limb Lymph Node Drainage During Axillary Reverse Mapping in Breast Cancer: A Prospective Observational Study 88
Combined IFN-γ and TNF-α treatment enhances the susceptibility of breast cancer cells and spheroids to Natural Killer cell-mediated killing 87
A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesothelioma 87
Inhibition of autophagy enhances the antitumor efficacy of T/CAR T cell against neuroblastoma 86
Effects of Angiogenic Factors on the Epithelial-to-Mesenchymal Transition and Their Impact on the Onset and Progression of Oral Squamous Cell Carcinoma: An Overview 85
Combining ERAP1 silencing and entinostat therapy to overcome resistance to cancer immunotherapy in neuroblastoma 84
Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma 84
The Multiple Roles of CD147 in the Development and Progression of Oral Squamous Cell Carcinoma: An Overview 83
NK cell receptors in anti-tumor and healthy tissue protection: Mechanisms and therapeutic advances 83
Dendritic cells: Behind the scenes of t-cell infiltration into the tumor microenvironment 81
Counter-regulation of regulatory T cells by autoreactive CD8 + T cells in rheumatoid arthritis 77
Targeting the antigen processing and presentation pathway to overcome resistance to immune checkpoint therapy. 77
MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma 77
A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy people 76
MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma 76
ERAP1 and ERAP2 enzymes: A protective shield for ras against COVID-19? 75
Tumor-infiltrating T cells and PD-L1 expression in childhood malignant extracranial germ-cell tumors 75
Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors 75
Crosstalk and communication of cancer-associated fibroblasts with natural killer and dendritic cells: New frontiers and unveiled opportunities for cancer immunotherapy 74
Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma 74
Common gene variants within 3′-untranslated regions as modulators of multiple myeloma risk and survival 73
A Novel Panel of Serum Biomarkers for MPM Diagnosis 72
Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism 71
Eif4g1 and ran as possible drivers for malignant pleural mesothelioma 71
Mesothelin promoter variants are associated with increased soluble mesothelin-related peptide levels in asbestos-exposed individuals 71
The landscape of combining immune checkpoint inhibitors with novel Therapies: Secret alliances against breast cancer 68
Expression status of candidate genes in mesothelioma tissues and cell lines 64
A genome-wide shRNA screen uncovers a novel potential ligand for NK cell activating receptors 64
Characterization of novel 3′untranslated regions and related polymorphisms of the gene NPPC, encoding for the C-type natriuretic peptide 63
A comprehensive meta-analysis of case-control association studies to evaluate polymorphisms associated with the risk of differentiated thyroid carcinoma 62
Functional polymorphism within NUP210 encoding for nucleoporin GP210 is associated with the risk of endometriosis 61
A methodological reappraisal of total and high molecular weight adiponectin determination in human peripheral circulation: comparison of four immunometric assays 59
Impact of natural occurring erap1 single nucleotide polymorphisms within mirna-binding sites on hcmv infection 58
Correction: MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma (PLoS ONE (2017) 12:6 (e0180317) DOI: 10.1371/journal.pone.0085935) 56
Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines 56
Editorial: Cell network in antitumor immunity of pediatric and adult solid tumors 56
Two bullets in the gun: combining immunotherapy with chemotherapy to defeat neuroblastoma by targeting adrenergic-mesenchymal plasticity 56
Clinical Feature Ranking Based on Ensemble Machine Learning Reveals Top Survival Factors for Glioblastoma Multiforme 54
Role of genetic variations on MHC class I antigen-processing genes in human cancer and viral-mediated diseases 53
The multifaceted role of agents counteracting metabolic syndrome: A new hope for gastrointestinal cancer therapy 52
Risk of differentiated thyroid carcinoma and polymorphisms within the susceptibility cancer region 8q24 50
Correction: Inhibition of autophagy enhances the antitumor efficacy of T/CAR T cell against neuroblastoma 45
The regulatory roles of phosphatases in cancer 43
The HIV Protease Inhibitor Ritonavir Reverts the Mesenchymal Phenotype Induced by Inflammatory Cytokines in Normal and Tumor Oral Keratinocytes to an Epithelial One, Increasing the Radiosensitivity of Tumor Oral Keratinocytes 42
Polymorphisms within base and nucleotide excision repair pathways and risk of differentiated thyroid carcinoma 41
Mapping B cells and the immune landscape of tertiary lymphoid structures reveals their clinical impact in neuroblastoma 41
Editorial: Community series in cell network in antitumor immunity of pediatric and adult solid tumors, volume II 36
PD-1+ NK cell subsets in high grade serous ovarian cancer: an indicator of disease severity and a target for combined immune-checkpoint blockade 34
Lactate-mediated NK cell dysfunction as a prognostic marker and therapeutic target in breast cancer 14
Intestinal epithelial Smad7 drives purine metabolic dysregulation and ileal inflammation 13
Fibronectin Is a Likely Therapeutic Target Shared by Oral and Breast Carcinomas 12
Transforming growth factor β induced as a novel secreted immune checkpoint counterinhibiting human tumor-associated T cells 11
Totale 5.955
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.996
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.996
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202260 0 6 1 0 0 9 5 3 6 3 4 23
2022/2023503 8 7 44 48 52 118 60 28 56 15 57 10
2023/2024247 27 16 20 6 35 62 12 7 12 19 4 27
2024/20251.410 21 214 133 103 45 199 84 43 87 93 282 106
2025/20262.856 217 117 222 186 253 92 471 284 341 245 224 204
2026/2027695 628 67 0 0 0 0 0 0 0 0 0 0
Totale 5.955